Stock Events

Stock Events

Galectin Therapeutics (GALT) Q2 2026 Earnings

May 15Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.2

-0.15

-0.11

-0.06

Details

Expected EPS

-0.06

Actual EPS

-0.08

Surprise EPS

-0.02

Surprise Percent

-33.33%

Description

⁨Galectin Therapeutics⁩ (⁦GALT⁩) has reported earnings of ⁦-0.08⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.